Apellis Pharmaceuticals
APLS
APLS
281 hedge funds and large institutions have $7B invested in Apellis Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 79 increasing their positions, 108 reducing their positions, and 33 closing their positions.
Holders
281
Holders Change
+27
Holders Change %
+10.63%
% of All Funds
4.12%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.13%
New
64
Increased
79
Reduced
108
Closed
33
Calls
$379M
Puts
$133M
Net Calls
+$247M
Net Calls Change
+$11.8M
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
326
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
PA
327
Perceptive Advisors
New York
| – | – | – | – |
|
328
IMC Chicago
Chicago,
Illinois
| – | – | – | – |
|
|
HT
329
HAP Trading
New York
| – | – | – | – |
|